Furthermore, thyroid cancer cells exposed to sunitinib dose dependent treatments showed significant Caspase 3 cleavage, P21, and P27 protein expressions, whereas P53 was not affected (Fig. 5D, Fig. 4B). This evidence concerns the gene CASP3 and thyroid cancer.